05 Jul [MCE] Target Protein for ADCs
Antibody-drug conjugates (ADCs) are a new class of anti-tumor drugs formed by coupling a specific monoclonal antibody to a cytotoxic drug through a linker. ADCs usually consist of a fully-humanized monoclonal antibody (mAb), a cytotoxic drug and a suitable linker. The primary role of the antibody component...